Product Information
MAXALT 10 MG TABLET is a brand product labeled by Organon LLC, priced at $44.4765 per EA under NDC 78206014201. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the rizatriptan benzoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Organon LLCNDC
78206014201
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
New Drug (NDA)
FDA Application
NDA020864On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for MAXALT 10 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $44.4765 per EA |
|---|---|
| All-time high | $44.4765 (Jun 24, 2026) |
| All-time low | $40.2131 (Apr 17, 2024) |
| 52-week high | $44.4765 |
| 52-week low | $42.3586 |
| Median price | $42.4544 |
| Average price | $42.2036 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MAXALT 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MAXALT 10 MG TABLET, manufactured by Organon LLC, is $44.4765 per EA (NDC 78206014201), effective Jun 24, 2026.
How has the price of MAXALT 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for MAXALT 10 MG TABLET has risen 10.6%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MAXALT 10 MG TABLET?
Since Apr 17, 2024, the NADAC for MAXALT 10 MG TABLET has ranged from a low of $40.2131 (Apr 17, 2024) to a high of $44.4765 (Jun 24, 2026), with a median of $42.4544 per EA.
Are there cheaper alternatives to MAXALT 10 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIZATRIPTAN 10 MG TABLET, is $0.5115 per EA — about 99% below MAXALT 10 MG TABLET.
Who manufactures MAXALT 10 MG TABLET?
MAXALT 10 MG TABLET (NDC 78206014201) is labeled by Organon LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification